GNMK - GenMark Diagnostics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
8.06
-0.05 (-0.62%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close8.11
Open8.09
Bid0.00 x 0
Ask0.00 x 0
Day's Range8.00 - 8.18
52 Week Range8.00 - 13.67
Volume238,043
Avg. Volume432,027
Market Cap440.62M
Beta0.39
PE Ratio (TTM)-6.61
EPS (TTM)-1.22
Earnings DateNov 1, 2017 - Nov 6, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.36
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to GenMark Diagnostics, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GenMark Diagnostics, Inc. Here are 5 ETFs with the largest exposure to GNMK-US. Comparing the performance and risk of GenMark Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Is GenMark Diagnostics Inc (GNMK) Undervalued?
    Simply Wall St.6 days ago

    Is GenMark Diagnostics Inc (GNMK) Undervalued?

    GenMark Diagnostics Inc (NASDAQ:GNMK), a healthcare equipment and supplies company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGM, rising toRead More...

  • Capital Cube14 days ago

    ETFs with exposure to GenMark Diagnostics, Inc. : October 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GenMark Diagnostics, Inc. Here are 5 ETFs with the largest exposure to GNMK-US. Comparing the performance and risk of GenMark Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
    Capital Cube15 days ago

    GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017

    Categories: Yahoo FinanceGet free summary analysis GenMark Diagnostics, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 12.36 million, Net Earnings of USD -17.99 million. Gross margins narrowed from 62.28% to 39.52% compared to the same period last year, operating (EBITDA) margins now -129.70% from -93.49%. Change in operating ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of GNMK earnings conference call or presentation 1-Aug-17 12:30pm GMT

    Q2 2017 GenMark Diagnostics Inc Earnings Call

  • Capital Cube2 months ago

    GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : August 8, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GenMark Diagnostics, Inc. a score of 25. Our analysis is based on comparing GenMark Diagnostics, Inc. with the following peers – QIAGEN NV, PerkinElmer, Inc., Alere Inc., Luminex Corp and Hologic, Inc. (QGEN-US, PKI-US, ALR-US, LMNX-US and HOLX-US). Investment Outlook GenMark Diagnostics, Inc. has a fundamental score ... Read more (Read more...)

  • Associated Press3 months ago

    GenMark Diagnostics reports 2Q loss

    On a per-share basis, the Carlsbad, California-based company said it had a loss of 37 cents. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks ...

  • Business Wire3 months ago

    GenMark Reports Second Quarter 2017 Results

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the second quarter ended June 30, 2017.

  • ACCESSWIRE3 months ago

    Investor Network: GenMark Diagnostics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 1, 2017 / GenMark Diagnostics, Inc. (NASDAQ: GNMK ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 01, 2017 at 8:30 ...

  • Business Wire3 months ago

    GenMark Diagnostics to Attend Canaccord Genuity’s 37th Annual Growth Conference

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that President and Chief Executive Officer, Hany Massarany, will attend the 2017 Canaccord Genuity Growth Conference in Boston.

  • GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : July 27, 2017
    Capital Cube3 months ago

    GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : July 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GenMark Diagnostics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Business Wire4 months ago

    GenMark Diagnostics Prices Upsized Public Offering of Common Stock

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the upsizing and pricing of its previously announced underwritten public offering of 6,382,978 shares of its common stock at a public offering price of $11.75 per share.

  • Business Wire4 months ago

    GenMark Diagnostics Commences Public Offering of Common Stock

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that it has commenced an underwritten public offering of $65,000,000 of shares of its common stock.

  • Capital Cube4 months ago

    GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : June 12, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GenMark Diagnostics, Inc. a score of 28. Our analysis is based on comparing GenMark Diagnostics, Inc. with the following peers – QIAGEN NV, PerkinElmer, Inc., Alere Inc., Luminex Corp and Hologic, Inc. (QGEN-US, PKI-US, ALR-US, LMNX-US and HOLX-US). Investment Outlook GenMark Diagnostics, Inc. has a fundamental score ... Read more (Read more...)

  • Business Wire4 months ago

    GenMark Receives FDA 510(k) Market Clearance for Its ePlex® Instrument and Respiratory Pathogen Panel

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received 510 market clearance from the U.S.

  • GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : June 9, 2017
    Capital Cube4 months ago

    GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : June 9, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GenMark Diagnostics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Business Wire5 months ago

    GenMark Diagnostics to Present at the 2017 William Blair Growth Stock Conference

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the 2017 William Blair Growth Stock Conference in Chicago on Tuesday, June 13, 2017.

  • Capital Cube5 months ago

    ETFs with exposure to GenMark Diagnostics, Inc. : May 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GenMark Diagnostics, Inc. Here are 5 ETFs with the largest exposure to GNMK-US. Comparing the performance and risk of GenMark Diagnostics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of GNMK earnings conference call or presentation 2-May-17 8:30pm GMT

    Q1 2017 GenMark Diagnostics Inc Earnings Call

  • GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : May 5, 2017
    Capital Cube5 months ago

    GenMark Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : GNMK-US : May 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GenMark Diagnostics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017
    Capital Cube6 months ago

    GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017

    Categories: Yahoo FinanceGet free summary analysis GenMark Diagnostics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of GenMark Diagnostics, Inc. – QIAGEN NV and Luminex Corp (QGEN-US and LMNX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 12.54 million, Net ... Read more (Read more...)

  • Business Wire6 months ago

    GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas, Nevada, on Tuesday, May 16, 2017.

  • Associated Press6 months ago

    GenMark Diagnostics reports 1Q loss

    The Carlsbad, California-based company said it had a loss of 30 cents per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...

  • Accesswire6 months ago

    Investor Network: GenMark Diagnostics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 2, 2017 / GenMark Diagnostics, Inc. (NASDAQ: GNMK) will be discussing their earnings results in their Q1 Earnings Call to be held May 2, 2017 at 4:30 PM Eastern Time. To ...